DSM-Firmenich AG DSFIR
EURONEXT · Netherlands · Consumer Non-Durables
€97.22-0.36 (-0.37%)
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Here is how Anheuser-Busch Inbev (BUD) and DSM Firmenich AG - Sponsored ADR (DSFIY) have performed compared to their sector so far this year.
The pursuit of healthy, resilient and flawless-looking skin is redefining beauty innovation across Asia Pacific. As consumer expectations continue to evolve, dsm-firmenich Beauty & Care is advancing epidermal science through CORNEOCARE™ 2.0, a holistic platform that highlight new scientific insights and ingredient innovations that address two highly relevant skin care needs in the region: Sensitive Skin and Flawless Skin.
Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), September 8, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 9, 2026 its intention to repurchase ordinary shares with an aggregate market value of €500 million and reduce its issued capital. On March 12, 2026, the company commenced repurchasing ordinary shares for a total amount of €540 million, of which €40
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.